Weight Loss & Metabolic
GLP-1s, retatrutide, AOD-9604 and metabolic research discussion. 34 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in Weight Loss & Metabolic
- My Apollo Stack Run: Appetite, Nausea & A outspoken Body Fat Drop - 2 points, 3 comments
- CagriSema titration: my nausea pattern & appetite changes - 1 points, 0 comments
- tirzepatide titration from 2.5 mg to 7.5 mg: my nausea pattern - 2 points, 2 comments
- Retatrutide: New GLP‑1 combo delivers 28% weight loss in trials - 1 points, 0 comments
- Oral GLP‑1 hits China’s late‑stage bar, US data still pending - 2 points, 3 comments
- My 8‑week Mazdutide titration – what to expect with nausea and liver fat loss - 2 points, 2 comments
- Retatrutide weight loss but heart rate oddity? - 2 points, 4 comments
- Head to head GLP-1 study from UGA - 2 points, 4 comments
- First week on CagriSema, appetite, nausea and weight tracking notes - 8 points, 6 comments
- Trying MOTS-c with low-dose semaglutide – early weight and HRV notes - 10 points, 5 comments
- My 6‑week CagriSema titration: appetite dip, nausea spikes and a weird HRV bump - 9 points, 4 comments
- Tracking my retatrutide titration – weight, appetite and HRV notes so far - 9 points, 4 comments
- CagriSema vs AOD-9604 for weight loss - 17 points, 4 comments
- First 4 weeks on AOD-9604: weight, appetite and any sides? - 10 points, 4 comments
- My 8‑week trial of CagriSema: appetite dip, nausea spikes, and a weird HRV bump - 9 points, 4 comments
- New triple‑target drug shows huge weight loss but safety still unclear - 14 points, 4 comments
- Retatrutide Shows Near‑Surgical Weight Loss in Phase 3 – Is It Realistic for Us? - 13 points, 4 comments
- Low dose semaglutide and my step count dropped – has anyone else seen this? - 10 points, 6 comments
- My first 6 weeks on oral Orforglipron – dose tweaks, nausea and step dip - 22 points, 4 comments
- GLP‑1 users may be walking less – does the weight loss win outweigh the activity dip? - 17 points, 3 comments
- thinking about adding Amlexanox to my current setup - 12 points, 3 comments
- My first 4‑week run with the Apollo stack – dosing tweaks and what I felt - 14 points, 4 comments
- My first 8‑week titration with Survodutide – appetite drop and a strange energy dip - 13 points, 4 comments
- Trying SLU-PP-332 as an “exercise mimetic” – my first 4‑week run - 21 points, 4 comments
- Tracking my results with Amlexanox and insulin sensitivity - 11 points, 4 comments
- FDA cracking down on telehealth claims - 7 points, 6 comments
- FDA cracks down on telehealth GLP‑1 compounding claims - 8 points, 4 comments
- Semaglutide plateau after 12 weeks, anyone else hit this wall? - 22 points, 3 comments
- Semaglutide appetite is down, but my steps fell off too - 16 points, 4 comments
- Generic semaglutide is still way off for most of us, and that matters - 27 points, 4 comments
- Semaglutide appetite stalled at 1 mg, anybody else hit this wall? - 14 points, 7 comments
- Semaglutide appetite stalled at 1mg, anyone else hit this wall? - 18 points, 6 comments
- Semaglutide Microdose Week Four: HRV, Glucose, and Appetite Notes - 13 points, 4 comments
- Semaglutide titration log week 8, HRV trends and nausea patterns - 23 points, 6 comments
Related compounds
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
- Tirzepatide - Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
- Retatrutide - Retatrutide (Triple Agonist GIP/GLP-1/Glucagon)
- Tesofensine - Tesofensine (Triple Monoamine Reuptake Inhibitor)
- CagriSema - CagriSema (Cagrilintide + Semaglutide)
- Survodutide - Survodutide (Dual GLP-1/Glucagon Agonist)
- Orforglipron - Orforglipron (Oral Non-Peptide GLP-1 Agonist)
Community discussion - research and educational context only. Not medical advice.